Sartorius Stedim Biotech GmbH and Bayer Technology Services GmbH (BTS), both located in Germany, have signed an exclusive cooperation agreement for the manufacture and worldwide marketing of UVivatec® products. With the technology, developed by BTS, viruses are inactivated in biopharmaceuticals by UVC irradiation.

Typical areas of use are virus inactivation of cell culture media, antibody solutions and solutions containing recombinant proteins as well as irradiation of vaccines and therapeutics produced from blood and plasma.The technology is scalable and marketed by Sartorius Stedim Biotech as single-use modules, laboratory bench units and process systems. BTS will actively work with Sartorius Stedim Biotech on advancing this technology

Leave a Reply